Mediaalpha Intrinsic Value Calculator – MEDIAALPHA Reports Q2 FY2023 Earnings Results for June 30th
August 22, 2023
🌥️Earnings Overview
MEDIAALPHA ($NYSE:MAX) has released its financial results for the second quarter of FY2023, ending June 30, 2023. Total revenues amounted to USD 84.8 million, representing a year-on-year decrease of 18.1%. Net income for the quarter was -14.3 million, compared to last year’s -9.1 million.
Market Price
On Wednesday, MEDIAALPHA reported its earnings results for the second quarter of FY2023, ending on June 30th. The stock opened at $9.5 and closed at $8.9, a drop of 8.2% from its previous closing price of $9.7. This decrease in the stock price reflects investors’ concerns over the company’s performance in the second quarter. The company reported mixed results from the second quarter, with revenue increasing by 3% compared to the same period last year, but net income decreasing by 4%.
This was due to higher operating expenses related to increased investments in research and development, as well as marketing campaigns to promote new products. Analysts remain cautiously optimistic about the company’s future prospects, given its strong track record of innovation and product development. Despite the recent drop in stock price, the company’s long-term outlook remains positive as it continues to focus on growth and profitability. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Mediaalpha. MEDIAALPHA_Reports_Q2_FY2023_Earnings_Results_for_June_30th”>More…
| Total Revenues | Net Income | Net Margin |
| 409.43 | -66 | -16.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Mediaalpha. MEDIAALPHA_Reports_Q2_FY2023_Earnings_Results_for_June_30th”>More…
| Operations | Investing | Financing |
| 24.72 | -0.07 | -39.82 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Mediaalpha. MEDIAALPHA_Reports_Q2_FY2023_Earnings_Results_for_June_30th”>More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 140.2 | 234.59 | -0.35 |
Key Ratios Snapshot
Some of the financial key ratios for Mediaalpha are shown below. MEDIAALPHA_Reports_Q2_FY2023_Earnings_Results_for_June_30th”>More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -5.1% | -51.9% | 7.5% |
| FCF Margin | ROE | ROA |
| 6.0% | -129.7% | 13.6% |
Analysis – Mediaalpha Intrinsic Value Calculator
At GoodWhale, we conducted an analysis of MEDIAALPHA‘s financials and have determined that the fair value of their shares is around $12.3. This figure was determined by our proprietary Valuation Line, which takes into account several factors such as the company’s projected cash flows, the cost of capital, and the risks associated with the investment. Currently, MEDIAALPHA stock is being traded at $8.9, which is undervalued by 27.4%. This is an excellent opportunity for investors to take advantage of MEDIAALPHA’s undervalued position and get in at a discounted rate. More…
Peers
The company operates in the US, Canada, and the UK. The company was founded in 2006 and is headquartered in San Francisco, California. MediaAlpha Inc’s competitors include EverQuote Inc, iSelect Ltd, and PB Fintech Ltd.
– EverQuote Inc ($NASDAQ:EVER)
EverQuote is an online marketplace for insurance shopping and comparison. The company operates a website and mobile app that connects consumers with insurance providers. EverQuote also offers a number of tools and resources to help consumers make informed decisions about their insurance coverage.
As of 2022, EverQuote had a market capitalization of $251.11 million and a return on equity of -17.71%. The company’s negative return on equity indicates that it is not generating sufficient profits to cover its costs of capital. EverQuote’s primary source of revenue is commissions from insurance providers, which means that its business is largely dependent on the insurance industry.
– iSelect Ltd ($ASX:ISU)
A market cap of 66.02M as of 2022 and a ROE of -9.14%
A brief intro of the company:
Ionis Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of ribonucleic acid-targeted drugs. It operates through the following segments: Commercial, Research and Development, and Corporate and Other. The Commercial segment refers to the sale of approved products. The Research and Development segment focuses on the discovery and development of drugs. The Corporate and Other segment covers the expenses not attributed to the commercial or research and development segments. The company was founded by Stanley T. Crooke in 1989 and is headquartered in Carlsbad, CA.
– PB Fintech Ltd ($BSE:543390)
PB Fintech Ltd is a financial technology company that operates in the global market. The company offers a range of services, including online banking, mobile banking, and payments. The company has a market cap of 169.39B as of 2022 and a Return on Equity of -10.53%.
Summary
MEDIAALPHA reported its second quarter FY2023 earnings results, with total revenue declining 18.1% year-over-year to USD 84.8 million. The net income for the quarter was USD -14.3 million, which is worse than the previous quarter’s figure of -9.1 million. This has had a negative effect on the stock price, which moved downwards on the same day.
For investors, this signals a period of uncertainty and potential challenges for the company going forward. Nevertheless, MEDIAALPHA could still offer investors attractive opportunities with its strong presence in the market and potential for long-term growth.
Related Posts
Recent Posts
